Affordable Access

Publisher Website

Etiology of sporadic Alzheimer’s disease: Somatostatin, neprilysin, and amyloid β peptide

Authors
Journal
Medical Hypotheses
0306-9877
Publisher
Elsevier
Publication Date
Volume
65
Issue
3
Identifiers
DOI: 10.1016/j.mehy.2005.02.045
Disciplines
  • Medicine

Abstract

Summary We recently demonstrated that amyloid β peptide (Aβ) is catabolized primarily by a neutral endopeptidase, neprilysin, in the brain and that a neuropeptide, somatostatin (SST), regulates brain Aβ level via modulation of neprilysin activity. Because SST expression in the brain declines upon aging in various mammals including rodents, apes and humans, we hypothesize that the aging-dependent reduction of SST triggers accumulation of Aβ in the brain by suppressing neprilysin action. This hypothesis accounts for the fact that aging is the predominant risk factor for Sporadic Alzheimer’s disease.

There are no comments yet on this publication. Be the first to share your thoughts.